(Q87757090)

English

Bladder cancer

scientific article published on 23 June 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27345655%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference

Europe PubMed Central

Bladder cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27345655%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

9

object named as

Wassim Kassouf

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27345655%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

author name string

Ashish M Kamat

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27345655%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Noah M Hahn

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27345655%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Jason A Efstathiou

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27345655%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Seth P Lerner

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27345655%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Per-Uno Malmström

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27345655%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Woonyoung Choi

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27345655%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Charles C Guo

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27345655%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Yair Lotan

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27345655%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

language of work or name

0 references

publication date

23 June 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27345655%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27345655%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

388

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27345655%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

2796-2810

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27345655%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

10061

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27345655%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Quality of care in patients with bladder cancer: a case report?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Histologic grading of urothelial carcinoma: a reappraisal.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Histologic grading of noninvasive papillary urothelial neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of Progression of Non–Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The pathology of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Pitfalls in the use of smoothelin to identify muscularis propria invasion by urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic use of antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary bladder tumor (TURBT) specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonurothelial bladder cancer and rare variant histologies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of variant histology on the outcome of bladder cancer treated with curative intent

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential expression of GATA-3 in urothelial carcinoma variants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical panel to identify the primary site of invasive micropapillary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinicopathological characteristics and outcome of nested carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasmacytoid carcinoma of the bladder: a urothelial carcinoma variant with a predilection for intraperitoneal spread.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Challenges in the pathology of non-muscle-invasive bladder cancer: a dialogue between the urologic surgeon and the pathologist

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Focus on bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive molecular characterization of urothelial bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequent truncating mutations of STAG2 in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Telomerase in bladder cancer: back to a better future?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological determinants of bladder cancer gene expression subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A molecular taxonomy for urothelial carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

New insights into subtypes of invasive bladder cancer: considerations of the clinician

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bladder cancers arise from distinct urothelial sub-populations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic opportunities in the intrinsic subtypes of muscle-invasive bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, an

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Time lag to diagnosis of bladder cancer--influence of psychosocial parameters and level of health-care provision

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of tumour size on recurrence and progression in Ta/T1 carcinoma of the urinary bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Early results of bladder-cancer screening in a high-risk population of heavy smokers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening with urinary dipsticks for reducing morbidity and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bladder cancer detection in patients with gross haematuria: Computed tomography urography with enhancement-triggered scan versus flexible cystoscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Urinary Biomarkers for Diagnosis of Bladder Cancer: A Systematic Review and Meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO/ICUD consensus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Urine markers for detection and surveillance of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective validation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Guérin therapy for bladder cancer: results of a prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel fluorescence in situ hybridization-based definition of bacille Calmette-Guérin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving selection criteria for early cystectomy in high-grade t1 bladder cancer: a meta-analysis of 15,215 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes of cT1 micropapillary bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of tumor-free status in repeat resection before intravesical bacillus Calmette-Guerin for high grade Ta, T1 and CIS bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The value of a second transurethral resection in evaluating patients with bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Car

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravesical chemotherapy prophylaxis in primary superficial bladder cancer: a meta-analysis of 3703 patients from 11 randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Myths and mysteries surrounding bacillus Calmette-Guérin therapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Side effects of Bacillus Calmette-Guérin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full d

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors and outcome in patients with T1 high-grade bladder cancer: can we identify patients for early cystectomy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of Systemic and Topical Drugs to Treat Non-muscle Invasive Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clarification of Bladder Cancer Disease States Following Treatment of Patients with Intravesical BCG.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical indications and outcomes with nerve-sparing cystectomy in patients with bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostatic urethral biopsy has limited usefulness in counseling patients regarding final urethral margin status during orthotopic neobladder reconstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Usefulness of transurethral biopsy for staging the prostatic urethra before radical cystectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ureteral and urethral frozen sections during radical cystectomy or cystoprostatectomy: an analysis of denudation and atypia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Utility and significance of ureteric frozen section analysis during radical cystectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome after radical cystectomy with limited or extended pelvic lymph node dissection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Re: Enhanced Recovery Protocol after Radical Cystectomy for Bladder Cancer: S. Daneshmand, H. Ahmadi, A. K. Schuckman, A. P. Mitra, J. Cai, G. Miranda and H. Djaladat J Urol 2014;192:50-56

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A Single-centre Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Robot-assisted radical cystectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial update.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bladder preservation strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bladder cancer: long-term follow-up results of patients treated with radical radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of superficial (T1) tumours of the bladder by radical radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of radical radiotherapy for the management of pT1G3 NXM0 transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Complications and long-term results of salvage cystectomy after failed bladder sparing therapy for muscle invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bladder cancer patterns of pelvic failure: implications for adjuvant radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted therapies in bladder cancer: an overview of in vivo research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The future of immune checkpoint therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930512-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(16)30512-8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27345655%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27345655%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q87757090&oldid=1410290771"